PT Pyridam Farma Tbk (IDX:PYFA)
Indonesia · Delayed Price · Currency is IDR 204.00
-2.00 (-0.97%)
Jun 19, 2026, 4:09 PM WIB
PT Pyridam Farma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,841,499 | 2,760,422 | 1,920,812 | 702,068 | 715,425 | 630,530 | |
Revenue Growth (YoY) | 15.76% | 43.71% | 173.59% | -1.87% | 13.46% | 127.30% |
Cost of Revenue | 2,251,653 | 2,183,094 | 1,394,225 | 407,050 | 464,580 | 385,949 |
Gross Profit | 589,846 | 577,328 | 526,587 | 295,017 | 250,845 | 244,581 |
Selling, General & Admin | 749,426 | 736,502 | 542,922 | 302,848 | 286,433 | 219,977 |
Other Operating Expenses | -1,143 | 5,108 | -17,577 | -9,632 | -25,604 | -26,508 |
Operating Expenses | 748,282 | 741,610 | 525,346 | 293,216 | 260,829 | 193,468 |
Operating Income | -158,436 | -164,282 | 1,242 | 1,801 | -9,985 | 51,113 |
Interest Expense | -323,072 | -318,136 | -212,198 | -85,795 | -86,911 | -41,927 |
Interest & Investment Income | 10,977 | 12,230 | 19,715 | 1,372 | 4,309 | 299.17 |
Currency Exchange Gain (Loss) | -2,039 | -7,055 | -4,847 | 78.47 | -278.68 | 160.29 |
Other Non Operating Income (Expenses) | -14,442 | -7,765 | -13,783 | -704.84 | -174.99 | -1,456 |
EBT Excluding Unusual Items | -487,012 | -485,007 | -209,871 | -83,248 | -93,040 | 8,189 |
Merger & Restructuring Charges | -24,015 | -33,126 | -103,273 | - | - | - |
Impairment of Goodwill | -12,737 | -12,737 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 6,296 | 622.44 |
Other Unusual Items | - | - | - | - | 349,824 | - |
Pretax Income | -523,763 | -530,870 | -313,144 | -83,248 | 263,080 | 8,811 |
Income Tax Expense | -153,810 | -151,200 | 17,102 | 1,979 | -12,392 | 3,332 |
Earnings From Continuing Operations | -369,953 | -379,670 | -330,246 | -85,226 | 275,472 | 5,479 |
Minority Interest in Earnings | 0.01 | 0.01 | -0.28 | 5.5 | -230.7 | - |
Net Income | -369,953 | -379,670 | -330,247 | -85,221 | 275,241 | 5,479 |
Net Income to Common | -369,953 | -379,670 | -330,247 | -85,221 | 275,241 | 5,479 |
Net Income Growth | - | - | - | - | 4923.61% | -75.21% |
Shares Outstanding (Basic) | 11,268 | 11,237 | 8,488 | 535 | 535 | 535 |
Shares Outstanding (Diluted) | 11,268 | 11,237 | 8,488 | 535 | 535 | 535 |
Shares Change (YoY) | 1.22% | 32.38% | 1486.34% | - | - | - |
EPS (Basic) | -32.83 | -33.79 | -38.91 | -159.27 | 514.39 | 10.24 |
EPS (Diluted) | -32.83 | -33.79 | -38.91 | -159.27 | 514.39 | 10.24 |
EPS Growth | - | - | - | - | 4923.61% | -75.21% |
Free Cash Flow | -563,352 | -503,734 | -251,873 | -117,347 | -31,832 | -179,149 |
Free Cash Flow Per Share | -50.00 | -44.83 | -29.67 | -219.31 | -59.49 | -334.81 |
Gross Margin | 20.76% | 20.91% | 27.41% | 42.02% | 35.06% | 38.79% |
Operating Margin | -5.58% | -5.95% | 0.07% | 0.26% | -1.40% | 8.11% |
Profit Margin | -13.02% | -13.75% | -17.19% | -12.14% | 38.47% | 0.87% |
Free Cash Flow Margin | -19.83% | -18.25% | -13.11% | -16.71% | -4.45% | -28.41% |
EBITDA | 13,348 | -18,073 | 110,218 | 53,991 | 55,363 | 77,872 |
EBITDA Margin | 0.47% | -0.66% | 5.74% | 7.69% | 7.74% | 12.35% |
D&A For EBITDA | 171,785 | 146,209 | 108,976 | 52,190 | 65,348 | 26,759 |
EBIT | -158,436 | -164,282 | 1,242 | 1,801 | -9,985 | 51,113 |
EBIT Margin | -5.58% | -5.95% | 0.07% | 0.26% | -1.40% | 8.11% |
Effective Tax Rate | - | - | - | - | - | 37.82% |